Global Oligonucleotides Market Insights and Forecast to 2028

Report ID: 1541633 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oligonucleotides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 DNA Oligos
        1.2.3 RNA Oligos
    1.3 Market by Application
        1.3.1 Global Oligonucleotides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pharmaceutical
        1.3.3 Research
        1.3.4 Diagnostic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oligonucleotides Market Perspective (2017-2028)
    2.2 Oligonucleotides Growth Trends by Region
        2.2.1 Oligonucleotides Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oligonucleotides Historic Market Size by Region (2017-2022)
        2.2.3 Oligonucleotides Forecasted Market Size by Region (2023-2028)
    2.3 Oligonucleotides Market Dynamics
        2.3.1 Oligonucleotides Industry Trends
        2.3.2 Oligonucleotides Market Drivers
        2.3.3 Oligonucleotides Market Challenges
        2.3.4 Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oligonucleotides Players by Revenue
        3.1.1 Global Top Oligonucleotides Players by Revenue (2017-2022)
        3.1.2 Global Oligonucleotides Revenue Market Share by Players (2017-2022)
    3.2 Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oligonucleotides Revenue
    3.4 Global Oligonucleotides Market Concentration Ratio
        3.4.1 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotides Revenue in 2021
    3.5 Oligonucleotides Key Players Head office and Area Served
    3.6 Key Players Oligonucleotides Product Solution and Service
    3.7 Date of Enter into Oligonucleotides Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotides Breakdown Data by Type
    4.1 Global Oligonucleotides Historic Market Size by Type (2017-2022)
    4.2 Global Oligonucleotides Forecasted Market Size by Type (2023-2028)
5 Oligonucleotides Breakdown Data by Application
    5.1 Global Oligonucleotides Historic Market Size by Application (2017-2022)
    5.2 Global Oligonucleotides Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oligonucleotides Market Size (2017-2028)
    6.2 North America Oligonucleotides Market Size by Type
        6.2.1 North America Oligonucleotides Market Size by Type (2017-2022)
        6.2.2 North America Oligonucleotides Market Size by Type (2023-2028)
        6.2.3 North America Oligonucleotides Market Share by Type (2017-2028)
    6.3 North America Oligonucleotides Market Size by Application
        6.3.1 North America Oligonucleotides Market Size by Application (2017-2022)
        6.3.2 North America Oligonucleotides Market Size by Application (2023-2028)
        6.3.3 North America Oligonucleotides Market Share by Application (2017-2028)
    6.4 North America Oligonucleotides Market Size by Country
        6.4.1 North America Oligonucleotides Market Size by Country (2017-2022)
        6.4.2 North America Oligonucleotides Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Oligonucleotides Market Size (2017-2028)
    7.2 Europe Oligonucleotides Market Size by Type
        7.2.1 Europe Oligonucleotides Market Size by Type (2017-2022)
        7.2.2 Europe Oligonucleotides Market Size by Type (2023-2028)
        7.2.3 Europe Oligonucleotides Market Share by Type (2017-2028)
    7.3 Europe Oligonucleotides Market Size by Application
        7.3.1 Europe Oligonucleotides Market Size by Application (2017-2022)
        7.3.2 Europe Oligonucleotides Market Size by Application (2023-2028)
        7.3.3 Europe Oligonucleotides Market Share by Application (2017-2028)
    7.4 Europe Oligonucleotides Market Size by Country
        7.4.1 Europe Oligonucleotides Market Size by Country (2017-2022)
        7.4.2 Europe Oligonucleotides Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oligonucleotides Market Size (2017-2028)
    8.2 Asia-Pacific Oligonucleotides Market Size by Type
        8.2.1 Asia-Pacific Oligonucleotides Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Oligonucleotides Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Oligonucleotides Market Share by Type (2017-2028)
    8.3 Asia-Pacific Oligonucleotides Market Size by Application
        8.3.1 Asia-Pacific Oligonucleotides Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Oligonucleotides Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Oligonucleotides Market Share by Application (2017-2028)
    8.4 Asia-Pacific Oligonucleotides Market Size by Region
        8.4.1 Asia-Pacific Oligonucleotides Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Oligonucleotides Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Oligonucleotides Market Size (2017-2028)
    9.2 Latin America Oligonucleotides Market Size by Type
        9.2.1 Latin America Oligonucleotides Market Size by Type (2017-2022)
        9.2.2 Latin America Oligonucleotides Market Size by Type (2023-2028)
        9.2.3 Latin America Oligonucleotides Market Share by Type (2017-2028)
    9.3 Latin America Oligonucleotides Market Size by Application
        9.3.1 Latin America Oligonucleotides Market Size by Application (2017-2022)
        9.3.2 Latin America Oligonucleotides Market Size by Application (2023-2028)
        9.3.3 Latin America Oligonucleotides Market Share by Application (2017-2028)
    9.4 Latin America Oligonucleotides Market Size by Country
        9.4.1 Latin America Oligonucleotides Market Size by Country (2017-2022)
        9.4.2 Latin America Oligonucleotides Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oligonucleotides Market Size (2017-2028)
    10.2 Middle East & Africa Oligonucleotides Market Size by Type
        10.2.1 Middle East & Africa Oligonucleotides Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Oligonucleotides Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Oligonucleotides Market Share by Type (2017-2028)
    10.3 Middle East & Africa Oligonucleotides Market Size by Application
        10.3.1 Middle East & Africa Oligonucleotides Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Oligonucleotides Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Oligonucleotides Market Share by Application (2017-2028)
    10.4 Middle East & Africa Oligonucleotides Market Size by Country
        10.4.1 Middle East & Africa Oligonucleotides Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Oligonucleotides Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Integrated DNA Technologies
        11.1.1 Integrated DNA Technologies Company Details
        11.1.2 Integrated DNA Technologies Business Overview
        11.1.3 Integrated DNA Technologies Oligonucleotides Introduction
        11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2017-2022)
        11.1.5 Integrated DNA Technologies Recent Developments
    11.2 Agilent
        11.2.1 Agilent Company Details
        11.2.2 Agilent Business Overview
        11.2.3 Agilent Oligonucleotides Introduction
        11.2.4 Agilent Revenue in Oligonucleotides Business (2017-2022)
        11.2.5 Agilent Recent Developments
    11.3 Sigma-aldrich
        11.3.1 Sigma-aldrich Company Details
        11.3.2 Sigma-aldrich Business Overview
        11.3.3 Sigma-aldrich Oligonucleotides Introduction
        11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2017-2022)
        11.3.5 Sigma-aldrich Recent Developments
    11.4 Eurofins Genomics
        11.4.1 Eurofins Genomics Company Details
        11.4.2 Eurofins Genomics Business Overview
        11.4.3 Eurofins Genomics Oligonucleotides Introduction
        11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2017-2022)
        11.4.5 Eurofins Genomics Recent Developments
    11.5 L.G.C Biosearch Technologies
        11.5.1 L.G.C Biosearch Technologies Company Details
        11.5.2 L.G.C Biosearch Technologies Business Overview
        11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction
        11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2017-2022)
        11.5.5 L.G.C Biosearch Technologies Recent Developments
    11.6 Eurogentec S.A
        11.6.1 Eurogentec S.A Company Details
        11.6.2 Eurogentec S.A Business Overview
        11.6.3 Eurogentec S.A Oligonucleotides Introduction
        11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2017-2022)
        11.6.5 Eurogentec S.A Recent Developments
    11.7 Nitto Denko Avecia Inc
        11.7.1 Nitto Denko Avecia Inc Company Details
        11.7.2 Nitto Denko Avecia Inc Business Overview
        11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction
        11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2017-2022)
        11.7.5 Nitto Denko Avecia Inc Recent Developments
    11.8 GenScript
        11.8.1 GenScript Company Details
        11.8.2 GenScript Business Overview
        11.8.3 GenScript Oligonucleotides Introduction
        11.8.4 GenScript Revenue in Oligonucleotides Business (2017-2022)
        11.8.5 GenScript Recent Developments
    11.9 BBI Life Sciences
        11.9.1 BBI Life Sciences Company Details
        11.9.2 BBI Life Sciences Business Overview
        11.9.3 BBI Life Sciences Oligonucleotides Introduction
        11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2017-2022)
        11.9.5 BBI Life Sciences Recent Developments
    11.10 GeneDesign
        11.10.1 GeneDesign Company Details
        11.10.2 GeneDesign Business Overview
        11.10.3 GeneDesign Oligonucleotides Introduction
        11.10.4 GeneDesign Revenue in Oligonucleotides Business (2017-2022)
        11.10.5 GeneDesign Recent Developments
    11.11 TriLink BioTechnologies
        11.11.1 TriLink BioTechnologies Company Details
        11.11.2 TriLink BioTechnologies Business Overview
        11.11.3 TriLink BioTechnologies Oligonucleotides Introduction
        11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2017-2022)
        11.11.5 TriLink BioTechnologies Recent Developments
    11.12 SGS DNA
        11.12.1 SGS DNA Company Details
        11.12.2 SGS DNA Business Overview
        11.12.3 SGS DNA Oligonucleotides Introduction
        11.12.4 SGS DNA Revenue in Oligonucleotides Business (2017-2022)
        11.12.5 SGS DNA Recent Developments
    11.13 LC Sciences
        11.13.1 LC Sciences Company Details
        11.13.2 LC Sciences Business Overview
        11.13.3 LC Sciences Oligonucleotides Introduction
        11.13.4 LC Sciences Revenue in Oligonucleotides Business (2017-2022)
        11.13.5 LC Sciences Recent Developments
    11.14 Twist Bioscience
        11.14.1 Twist Bioscience Company Details
        11.14.2 Twist Bioscience Business Overview
        11.14.3 Twist Bioscience Oligonucleotides Introduction
        11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2017-2022)
        11.14.5 Twist Bioscience Recent Developments
    11.15 Creative Biogene
        11.15.1 Creative Biogene Company Details
        11.15.2 Creative Biogene Business Overview
        11.15.3 Creative Biogene Oligonucleotides Introduction
        11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2017-2022)
        11.15.5 Creative Biogene Recent Developments
    11.16 General Biosystems
        11.16.1 General Biosystems Company Details
        11.16.2 General Biosystems Business Overview
        11.16.3 General Biosystems Oligonucleotides Introduction
        11.16.4 General Biosystems Revenue in Oligonucleotides Business (2017-2022)
        11.16.5 General Biosystems Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Oligonucleotides Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of DNA Oligos
    Table 3. Key Players of RNA Oligos
    Table 4. Global Oligonucleotides Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Oligonucleotides Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Oligonucleotides Market Share by Region (2017-2022)
    Table 8. Global Oligonucleotides Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Oligonucleotides Market Share by Region (2023-2028)
    Table 10. Oligonucleotides Market Trends
    Table 11. Oligonucleotides Market Drivers
    Table 12. Oligonucleotides Market Challenges
    Table 13. Oligonucleotides Market Restraints
    Table 14. Global Oligonucleotides Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Oligonucleotides Revenue Share by Players (2017-2022)
    Table 16. Global Top Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotides as of 2021)
    Table 17. Ranking of Global Top Oligonucleotides Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Oligonucleotides Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Oligonucleotides Product Solution and Service
    Table 21. Date of Enter into Oligonucleotides Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Oligonucleotides Revenue Market Share by Type (2017-2022)
    Table 25. Global Oligonucleotides Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Oligonucleotides Revenue Market Share by Type (2023-2028)
    Table 27. Global Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Oligonucleotides Revenue Share by Application (2017-2022)
    Table 29. Global Oligonucleotides Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Oligonucleotides Revenue Share by Application (2023-2028)
    Table 31. North America Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Oligonucleotides Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Oligonucleotides Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Oligonucleotides Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Oligonucleotides Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Oligonucleotides Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Oligonucleotides Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Oligonucleotides Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Oligonucleotides Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Integrated DNA Technologies Company Details
    Table 62. Integrated DNA Technologies Business Overview
    Table 63. Integrated DNA Technologies Oligonucleotides Product
    Table 64. Integrated DNA Technologies Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 65. Integrated DNA Technologies Recent Developments
    Table 66. Agilent Company Details
    Table 67. Agilent Business Overview
    Table 68. Agilent Oligonucleotides Product
    Table 69. Agilent Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 70. Agilent Recent Developments
    Table 71. Sigma-aldrich Company Details
    Table 72. Sigma-aldrich Business Overview
    Table 73. Sigma-aldrich Oligonucleotides Product
    Table 74. Sigma-aldrich Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 75. Sigma-aldrich Recent Developments
    Table 76. Eurofins Genomics Company Details
    Table 77. Eurofins Genomics Business Overview
    Table 78. Eurofins Genomics Oligonucleotides Product
    Table 79. Eurofins Genomics Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 80. Eurofins Genomics Recent Developments
    Table 81. L.G.C Biosearch Technologies Company Details
    Table 82. L.G.C Biosearch Technologies Business Overview
    Table 83. L.G.C Biosearch Technologies Oligonucleotides Product
    Table 84. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 85. L.G.C Biosearch Technologies Recent Developments
    Table 86. Eurogentec S.A Company Details
    Table 87. Eurogentec S.A Business Overview
    Table 88. Eurogentec S.A Oligonucleotides Product
    Table 89. Eurogentec S.A Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 90. Eurogentec S.A Recent Developments
    Table 91. Nitto Denko Avecia Inc Company Details
    Table 92. Nitto Denko Avecia Inc Business Overview
    Table 93. Nitto Denko Avecia Inc Oligonucleotides Product
    Table 94. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 95. Nitto Denko Avecia Inc Recent Developments
    Table 96. GenScript Company Details
    Table 97. GenScript Business Overview
    Table 98. GenScript Oligonucleotides Product
    Table 99. GenScript Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 100. GenScript Recent Developments
    Table 101. BBI Life Sciences Company Details
    Table 102. BBI Life Sciences Business Overview
    Table 103. BBI Life Sciences Oligonucleotides Product
    Table 104. BBI Life Sciences Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 105. BBI Life Sciences Recent Developments
    Table 106. GeneDesign Company Details
    Table 107. GeneDesign Business Overview
    Table 108. GeneDesign Oligonucleotides Product
    Table 109. GeneDesign Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 110. GeneDesign Recent Developments
    Table 111. TriLink BioTechnologies Company Details
    Table 112. TriLink BioTechnologies Business Overview
    Table 113. TriLink BioTechnologies Oligonucleotides Product
    Table 114. TriLink BioTechnologies Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 115. TriLink BioTechnologies Recent Developments
    Table 116. SGS DNA Company Details
    Table 117. SGS DNA Business Overview
    Table 118. SGS DNA Oligonucleotides Product
    Table 119. SGS DNA Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 120. SGS DNA Recent Developments
    Table 121. LC Sciences Company Details
    Table 122. LC Sciences Business Overview
    Table 123. LC Sciences Oligonucleotides Product
    Table 124. LC Sciences Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 125. LC Sciences Recent Developments
    Table 126. Twist Bioscience Company Details
    Table 127. Twist Bioscience Business Overview
    Table 128. Twist Bioscience Oligonucleotides Product
    Table 129. Twist Bioscience Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 130. Twist Bioscience Recent Developments
    Table 131. Creative Biogene Company Details
    Table 132. Creative Biogene Business Overview
    Table 133. Creative Biogene Oligonucleotides Product
    Table 134. Creative Biogene Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 135. Creative Biogene Recent Developments
    Table 136. General Biosystems Company Details
    Table 137. General Biosystems Business Overview
    Table 138. General Biosystems Oligonucleotides Product
    Table 139. General Biosystems Revenue in Oligonucleotides Business (2017-2022) & (US$ Million)
    Table 140. General Biosystems Recent Developments
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oligonucleotides Market Share by Type: 2021 VS 2028
    Figure 2. DNA Oligos Features
    Figure 3. RNA Oligos Features
    Figure 4. Global Oligonucleotides Market Share by Application: 2021 VS 2028
    Figure 5. Pharmaceutical Case Studies
    Figure 6. Research Case Studies
    Figure 7. Diagnostic Case Studies
    Figure 8. Oligonucleotides Report Years Considered
    Figure 9. Global Oligonucleotides Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Oligonucleotides Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Oligonucleotides Market Share by Region: 2021 VS 2028
    Figure 12. Global Oligonucleotides Market Share by Players in 2021
    Figure 13. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotides as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Oligonucleotides Revenue in 2021
    Figure 15. North America Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 17. North America Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 18. North America Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 19. United States Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 25. Germany Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Oligonucleotides Market Size Share by Region (2017-2028)
    Figure 35. China Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 45. Mexico Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Oligonucleotides Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Oligonucleotides Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Oligonucleotides Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Oligonucleotides Market Size Share by Country (2017-2028)
    Figure 51. Turkey Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 55. Agilent Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 56. Sigma-aldrich Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 57. Eurofins Genomics Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 58. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 59. Eurogentec S.A Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 60. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 61. GenScript Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 62. BBI Life Sciences Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 63. GeneDesign Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 64. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 65. SGS DNA Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 66. LC Sciences Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 67. Twist Bioscience Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 68. Creative Biogene Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 69. General Biosystems Revenue Growth Rate in Oligonucleotides Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Frequently Asked Questions
Oligonucleotides report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oligonucleotides report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oligonucleotides report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Screw Jacks

Screw Jacks market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Part Feeders

Part Feeders market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More